CIK 0001101026
- Non-accelerated filer
- Smaller reporting company
Zivo Bioscience, Inc.
Sign in to watch- Ticker
- ZIVO
- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- Operating
- EIN
- 870699977
- Phone
- +1 248-452-9866
- Business address
- 21 E. LONG LAKE ROAD, SUITE 100, BLOOMFIELD HILLS, MI, 48304
- Former names
- HEALTH ENHANCEMENT PRODUCTS INC, WESTERN GLORY HOLE INC
- 4 Open-market buy Director bought 15,000 shares at $4.99 ($74,850)
- 4 Open-market buy Director bought 100,000 shares at $4.99 ($499,000)
- 3 Insider Initial Statement of Ownership
- 5 Insider Annual Insider Trading Report
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Shares withheld for taxes Director gave up 235,849 shares (to pay taxes)
- 4 Derivatives Options or other derivatives
- 4 Exercise or conversion Director acquired 250,000 shares (option exercise)
- 4 Shares withheld for taxes Chief Financial Officer gave up 235,849 shares (to pay taxes)
- 4 Exercise or conversion Director acquired 250,000 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 4 Exercise or conversion Director acquired 318,182 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Director bought 65,000 shares at an average $0.16 ($10,160)
- 4 Open-market buy Director bought 490,125 shares at an average $0.14 ($70,118)
Page 5 of 12 · 239 filings